Molecular Therapy Oncology
Molecular Therapy Oncology(英文缩写 MOL THER ONCOL),ISSN 2950-3299,eISSN 2950-3299 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
Molecular Therapy Oncology 最新收录文献
-
{"_":"A p53-selective bispecific T cell engager: Computational design and functional validation.","sup":["R273H"]}
TP53 mutations occur in over 50% of human cancers and generate shared neoantigens, including p53, which represents a compelling target for precision immunotherapy. However, HLA allele-specific present…
-
Erratum: AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.
[This corrects the article DOI: 10.1016/j.omton.2026.201253.].
-
{"_":"Erratum: Intramuscular plasmid DNA electroporation sequesters neoantigen-specific CD8 T cells in treated muscle and limits tumor infiltration.","sup":["+"]}
[This corrects the article DOI: 10.1016/j.omton.2026.201248.].
-
Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway.
Non-small cell lung cancers (NSCLCs) with inactivation of the tumor suppressor LKB1 are common and respond poorly to current therapies. We previously identified aberrant activation of the CRTC-CREB tr…
-
Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety.
Oncolytic virotherapy employing Coxsackievirus B3 has emerged as a promising and innovative strategy for cancer treatment. However, wild-type Coxsackievirus B3 is associated with significant organ tox…
-
USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells.
Aggressive metastasis and chemoresistance are underlying cause for the poor clinical outcome in ovarian cancer patients. Identifying factors that drive these phenotypes is critical in developing effec…
-
Dual targeting of PDPN and GD2 enhances CAR T cell efficacy against glioblastoma and promotes durable tumor control.
-
Precision medicine meets artificial intelligence: A new prognostic model for lower-grade glioma.
-
{"_":" scAAV-based NeuroD1 gene therapy inhibiting glioblastoma growth.","i":["In vivo"]}
-
Reversal of repeated red cards reprieves RP-1.